+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genocea Biosciences - logo

Genocea Biosciences is a biopharmaceutical company that develops novel vaccines and immunotherapies to treat infectious diseases. The company uses its proprietary discovery platform AnTigen Lead Acquisition System to design vaccines and immunotherapies that act through T cell immune responses. Its lead product candidate is GEN-003, a therapeutic vaccine or immunotherapy that is in Phase 2 trial for the treatment of genital herpes infections. Founded in 2006, it is headquartered in Cambridge, Massachusetts.

From
Chlamydia Drug Development Pipeline Study, H2 2018 - Product Thumbnail Image

Chlamydia Drug Development Pipeline Study, H2 2018

  • Report
  • August 2018
  • 60 Pages
From
From
From
Novel Vaccine Delivery Devices Market, 2019-2030 - Product Thumbnail Image

Novel Vaccine Delivery Devices Market, 2019-2030

  • Report
  • November 2019
  • 403 Pages
From
From
Global Pneumococcal Vaccine Market 2016-2020 - Product Thumbnail Image

Global Pneumococcal Vaccine Market 2016-2020

  • Report
  • August 2016
  • 82 Pages
From
Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2019 - Product Thumbnail Image

Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 272 Pages
From
Head And Neck Cancer - Pipeline Review, H2 2019 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 2792 Pages
From
From
From
From
From
Loading Indicator
adroll